Ogivri Prices, Coupons and Patient Assistance Programs
Ogivri (trastuzumab) is a member of the HER2 inhibitors drug class and is commonly used for Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, and others.
Ogivri Prices
This Ogivri price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Ogivri intravenous powder for injection dkst 150 mg is around $1,392 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Intravenous Powder For Injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $1,392.44 | $1,392.44 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $3,869.44 | $3,869.44 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Ogivri Coupons and Rebates
Ogivri offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Ogivri Myland Advocate Co-pay Assistance Program: Eligible commercially insured patients may save a maximum of $25,000 per 12-month period; for additional information contact the program at 833-695-2623.
| Applies to: | Ogivri |
| Number of uses: | per prescription per year |
Patient Assistance Programs for Ogivri
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Ogivri (trastuzumab-dkst) Injection; IV
Provider: Mylan Advocate Patient Support Program
Elligibility requirements:
- Contact program for details.
- Not disclosed
- Varies
- US residency requirements are not specified.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. Education and support services are available; Contact program for details. Fulphila: 1-833-695-2623 Glatiramer Acetate: 1-844-695-2667 Ogivri: 1-833-695-2623
Applicable drugs:
- Ogivri (trastuzumab-dkst) Injection; IV
More about Ogivri (trastuzumab)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: HER2 inhibitors
- FDA Approval History
Consumer resources
Other brands: Herceptin, Trazimera, Kanjinti, Herzuma, Ontruzant
